C=C1CCC2[C@H](OC(=O)[C@]2(O)CO)[C@H]2C(=C)C(O)C[C@@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?